Profile
Sandy D.
Der is the founder of ImmVue Therapeutics.
Dr. Der is a Partner at Novatio Ventures since 2015.
Dr. Der was COO at Ardra, Inc. from 2019 to 2022.
Dr. Der completed undergraduate and doctorate degrees at the University of Toronto in 1997.
Sandy Der active positions
| Companies | Position | Start |
|---|---|---|
Novatio Ventures
Novatio Ventures Investment ManagersFinance Novatio Ventures invests in companies located Canada, U.S., China, South Korea, and other markets. The firm focuses on companies in the filed of high-impact life science. It participates in seed and early stage capital requirements. | Private Equity Investor | 01/10/2015 |
Former positions of Sandy Der
| Companies | Position | End |
|---|---|---|
Ardra, Inc.
Ardra, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures petroleum-free and specialty chemicals | Chief Operating Officer | 01/12/2022 |
Training of Sandy Der
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardra, Inc.
Ardra, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures petroleum-free and specialty chemicals | Process Industries |
Novatio Ventures
Novatio Ventures Investment ManagersFinance Novatio Ventures invests in companies located Canada, U.S., China, South Korea, and other markets. The firm focuses on companies in the filed of high-impact life science. It participates in seed and early stage capital requirements. | Finance |
- Stock Market
- Insiders
- Sandy Der
















